Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 427

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 427
---
 is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |

| Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |

| Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2025 and December 31, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

| Assets:                           |     | As of June 30,2025    |           |     | Quoted Prices inActive Markets(Level 1) |   |     | SignificantOtherObservableInputs(Level 2) |           |     | SignificantOtherUnobservableInputs(Level 3) |   |
|:----------------------------------|:----|:----------------------|----------:|:----|:----------------------------------------|:--|:----|:------------------------------------------|----------:|:----|:--------------------------------------------|:--|
| Investments held in Trust Account |     | $                     |   548,318 |     | $                                       | — |     | $                                         |   548,318 |     |                                             | — |
|                                   |     | As ofDecember 31,2025 |           |     | Quoted Prices inActive Markets(Level 1) |   |     | SignificantOtherObservableInputs(Level 2) |           |     | SignificantOtherUnobservableInputs(Level 3) |   |
| Assets:                           |     |                       |           |     |                                         |   |     |                                           |           |     |                                             |   |
| Investments held in Trust Account |     | $                     | 9,021,005 |     | $                                       | — |     | $                                         | 9,021,005 |     |                                             | — |

NOTE 9 - SEGMENT INFORMATION ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker